Item
1.01 Entry into a Share Exchange Agreement.
Share Exchange Agreement
On August 23, 2019,
Legacy Acquisition Corp., a Delaware corporation (“Legacy” or “Purchaser”), entered into a Share Exchange
Agreement (the “Agreement”) with Blue Valor Limited, a company incorporated in Hong Kong and an indirect, wholly-owned
subsidiary of Blue Focus Intelligent Communications Group (the “Seller”). Pursuant to the Agreement, Legacy will purchase
all of the issued and outstanding shares of a to be formed wholly-owned holding company organized in the Cayman Islands that at
closing will hold the Blue Impact group business, a digital-first, global advertising and marketing services group (the “Blue
Impact business”). The transactions contemplated by the Agreement are referred to as the “Business Combination.”
Upon the consummation of the Business Combination, Legacy will change its name to Blue Impact Inc. and its shares of common stock
are expected to trade on the New York Stock Exchange.
The Blue Impact business
consists of (i) Vision 7 International Inc., a Canadian company, the wholly-owned subsidiaries of which include The Camps Collective,
Citizen Relations (including The Colony Project), Cossette Communications, Eleven LLC, Gene Global, K72, The Narrative Group, and
Vision7 Media (including Cossette Media, Impact Research and Jungle & Magnet); (ii) We Are Very Social Limited, a limited company
domiciled and incorporated in England and Wales, a wholly-owned subsidiary of which is Indigo Social, LLC, a Delaware limited liability
company; (iii) Metta Communications Limited, a private company limited by shares registered in Hong Kong; (iv) Madhouse Inc., a
Cayman Islands exempted company (“Madhouse”) (subject to the Purchaser’s payment for a minority interests in
Madhouse as provided herein); and (v) Fuse Project, LLC, a Delaware limited liability company.
Consideration
Closing Share Consideration.
Pursuant to the Agreement, at the closing, the Seller will receive 30 million shares of Class A common stock of Legacy, subject
to adjustment as set forth below (the “Closing Shares”), and Legacy expects to (a) assume $40 million of net debt related
to the Blue Impact business, (b) assume $48 million of deferred acquisition purchase price obligations, and (c) pay $90 million
to purchase or redeem certain minority interests of Madhouse. At the close of business on Thursday, August 22, the day before the
signing and announcement of the Agreement, the closing price of Legacy’s shares of Class A common stock was $10.17 per share.
The Closing Shares
will be subject to adjustment following closing based on the extent to which, as of the closing date, (a) the net debt of the Blue
Impact business, (b) the deferred acquisition purchase price obligations for the Blue Impact business (excluding Madhouse) and
(c) the amount of the purchase price for the minority interests of Madhouse, are each finally determined to be greater or less
than the targets for such amounts specified in the Agreement. The determinations as of the closing date of the foregoing amounts
will be mutually agreed to by the Seller and a committee of independent directors of the Purchaser with any disagreements being
resolved by a nationally recognized independent public accounting firm jointly selected by the Seller and the Purchaser.
Earn-out for Madhouse.
Up to $222 million may be payable after the 2022 audit is complete in the form of an incentive-based earn-out tied to average profit
growth of the Madhouse business over the three-year period ending December 31, 2022. The earn-out will be payable at Legacy’s
option in cash, stock or a combination thereof if Legacy’s common stock share price at the time of payment is greater than
$10 per share. If not, then dependent upon Legacy’s then-available cash, the earn-out will be payable in cash or subordinated
notes. Seller has partially and irrevocably assigned a portion of any earn-out payment to fund a long-term incentive plan to be
established for the benefit of designated individuals employed or associated with the group company business.
Representations, Warranties and Covenants
The parties to the
Agreement have made customary representations, warranties and covenants in the Agreement, including, among others, covenants for
the preparation of the Blue Impact business’ audited and interim financial statements, which will be presented in Legacy’s
proxy statement relating to the Business Combination to be filed with the SEC, and the completion of the Business Combination.
Legacy and Seller have each agreed to use commercially reasonable efforts to cause the Business Combination to be consummated.
Conditions to Closing
The closing of the
Business Combination is subject to certain conditions, including, among others, (i) approval by Legacy’s stockholders of
the Agreement, the Business Combination and certain other actions related thereto, (ii) the completion of the reorganization of
the Blue Impact business, (iii) delivery by Legacy to the Seller of evidence that Legacy has at least US$5,000,001 of net tangible
assets at closing and the funds contained in Legacy’s trust account equal at least US$120,000,000, in each case, following
any redemptions of shares by Legacy’s stockholders in connection with the Business Combination, (iv) the Blue Impact business
shall have a minimum of US$10,000,000 in cash, (v) the minority interest in Madhouse shall have been redeemed, (vi) the Seller’s
delivery to Legacy of certain audited financial statements of the Blue Impact business, (vii) the execution of a China commercial
collaboration and shared services agreement, an amended and restated registration rights agreement, an investor rights agreement
(containing certain voting rights, lock-up provisions, drag-along rights and rights of first offer in favor of the Seller), and
a redemption side letter, in each case, in the forms attached to the Agreement, (viii) the Purchaser shall have adopted an equity
incentive plan for an amount of Purchaser common stock representing 7.5% of the shares of capital stock of the Purchaser on the
closing date reserved for issuance under the equity incentive plan, (ix) the execution of an employment agreement with Legacy by
the chief executive officer of Vision 7, who will become the chief executive officer of the combined business following the closing
of the Business Combination, (x) certain amendments being made to the Purchaser’s certificate of incorporation and bylaws,
and (xi) the expiration or termination of the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act
of 1976, as amended.
Indemnification
From and after the
closing date, the Seller will indemnify and hold harmless Legacy and its controlled subsidiaries (which, following the closing,
will include the subsidiaries of the Blue Impact business) and their respective executives, managers, employees, agents and other
personnel or representatives (collectively, the “Indemnified Parties”) against and in respect of any and all losses,
interest, penalties, costs, expenses, actions, liabilities, taxes, judgments, deficiencies or damages suffered, incurred or sustained
by, or imposed upon the Indemnified Party to the extent arising in whole or in part out of or as a result of or in connection with
(whether or not involving a third party claim): (a) in the failure of any representation or warranty of the Seller contained in
the Agreement to be true and correct as of the date of the Agreement or as of the closing date; (b) any breach of any covenant,
agreement or undertaking made by the Seller or, with respect to any periods prior to the Closing Date, any company in the Blue
Impact business, in the Agreement or any related agreements; (c) any amounts owing to the Purchaser pursuant to the post-closing
adjustments to the consideration for the Business Combination pursuant to Section 2.8 of the Agreement; (d) any pre-closing indebtedness
of the Blue Impact business other than the assumed indebtedness; (e) the special tax indemnity (relating to the pre-closing operations
of Madhouse) (the “Special Tax Indemnity”); or (f) the reorganization tax indemnity (for taxes incurred in connection
with the reorganization) (the “Reorganization Tax Indemnity”).
Other than claims
based on fraud and claims relating to the Reorganization Tax Indemnity and the Special Tax Indemnity, Seller’s liability
for indemnification claims will be limited to $50,000,000 and subject to a deductible of $3,000,000. The Seller may resolve any
amounts owing to Legacy through either cash payments, or, in the event that an Earnout Payment (as described above) is earned,
a combination of cash, Legacy’s common stock or the reduction of any subordinated note due to the Seller as an earn-out payment.
Seller’s liability for claims arising under the Reorganization Tax Indemnity is limited to $5,000,000, subject to a deductible
of $500,000.
Purchaser may make
claims arising from breaches of the Sellers’ representations and warranties for a period of 3 years following the closing
date, breaches of the Seller’s covenants for so long as those covenants must be performed, under the Special Tax Indemnity
until the 10th anniversary of the closing date and under the Reorganization Tax Indemnity for the period beginning on the 3rd anniversary
of the closing date and ending on the 5th anniversary of the closing date.
The Seller has covenanted
to keep the Closing Shares available as a potential source of payment of its indemnification obligations for the period for which
the indemnification obligations survive the closing.
Termination
The Agreement may
be terminated by Legacy and Seller under certain circumstances, including, among others, (i) by mutual written consent of Legacy
and Seller, (ii) by Legacy or Seller if any permanent injunction or other permanent judgment issued by any court of competent jurisdiction
preventing the consummation of the transactions contemplated by the Agreement is in effect, (iii) by Legacy or Seller if the closing
has not occurred by 5:00 p.m., Eastern time, on May 20, 2020; (iv) by Legacy or Seller if Legacy’s stockholders do not approve
the Agreement, (v) by Legacy or Seller if the other party breaches or fails to perform in any material respect any of its representations,
warranties, covenants or other agreements contained in the Agreement (each subject to a 30 day cure period), (vi) by Legacy if
the Seller is unable to deliver certain historical financial statements of the Blue Impact business by October 15, 2019, or the
audited financial statements of the Blue Impact business as of September 30, 2019 and September 30, 2018 by December 15, 2019.
The foregoing description
of the Agreement and the Business Combination does not purport to be complete and is qualified in its entirety by the terms and
conditions of the Agreement, a copy of which is attached hereto as Exhibit 2.1 and is incorporated herein by reference. The
Agreement contains representations, warranties and covenants that the respective parties made to each other as of the date of such
agreement or other specific dates. The assertions embodied in those representations, warranties and covenants were made for purposes
of the contract among the respective parties and are subject to important qualifications and limitations agreed to by the parties
in connection with negotiating such agreement. The Agreement has been attached to provide investors with information regarding
its terms. It is not intended to provide any other factual information about Legacy, Seller or any other party to the Agreement.
In particular, the representations, warranties, covenants and agreements contained in the Agreement, which were made only for purposes
of such agreement and as of specific dates, were solely for the benefit of the parties to the Agreement, may be subject to limitations
agreed upon by the contracting parties (including being qualified by confidential disclosures made for the purposes of allocating
contractual risk between the parties to the Agreement instead of establishing these matters as facts) and may be subject to standards
of materiality applicable to the contracting parties that differ from those applicable to investors and reports and documents filed
with the U.S. Securities and Exchange Commission (the “SEC”). Investors should not rely on the representations, warranties,
covenants and agreements, or any descriptions thereof, as characterizations of the actual state of facts or condition of any party
to the Agreement. In addition, the representations, warranties, covenants and agreements and other terms of the Agreement may be
subject to subsequent waiver or modification. Moreover, information concerning the subject matter of the representations and warranties
and other terms may change after the date of the Agreement, which subsequent information may or may not be fully reflected in Legacy’s
public disclosures.